Dr Raj Singh previews key ASTRO 2026 data, from FMISO PET-guided de-escalation in HPV-positive head and neck cancer to SRS vs whole brain radiotherapy trials in brain metastases.
Raj Singh, MD
Advertisement
Raj Singh, MD, is a radiation oncologist at the Eugene M. and Christine E. Lynn Cancer Institute, part of Baptist Health.
Articles by Raj Singh, MD
Glioblastoma treatment still stalls beyond Stupp, while meningioma lacks systemic salvage options; Singh highlights adaptive trials, molecular profiling, and young-patient quality-of-life risks.
Raj Singh, MD, discusses treatment gaps, emerging therapies, and the critical role of multidisciplinary care in managing brain tumors.
Dr Raj Singh discusses radiation strategies, dose escalation, PCI debates, and multidisciplinary collaboration in small cell lung cancer management.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Expanding the Role of Immunotherapy in Lymphoma
2
SurVaxM Improves OS Only in Younger Subgroup in Newly Diagnosed Glioblastoma
3
CLL Treatment Enters a New Era of Targeted Combinations
4
Psilocybin-Assisted Therapy Aims at Existential Distress in Lung Cancer
5